Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine Add-on Therapy for Acute Exacerbations in Bipolar Disorders
NCT00186017Phase 4Completed
- Sponsor
- Stanford University
- Start
- Jul 2005
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in bipolar disorder (BD) comparing Olanzapine/Zyprexa with Placebo (2 arms). Primary endpoint: Clinical Global Impressions-Bipolar Version Overall Severity at 1 week. Started Jul 2005; status: completed.
02
Drugs
olanzapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00186017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00186017.